AR028743A1 - DERIVADOS DE N-TRIAZOLILMETIL-PIPERAZINA CON ACCIoN ANTAGONISTA DE RECEPTORES DE NEUROQUININA - Google Patents

DERIVADOS DE N-TRIAZOLILMETIL-PIPERAZINA CON ACCIoN ANTAGONISTA DE RECEPTORES DE NEUROQUININA

Info

Publication number
AR028743A1
AR028743A1 ARP010102959A ARP010102959A AR028743A1 AR 028743 A1 AR028743 A1 AR 028743A1 AR P010102959 A ARP010102959 A AR P010102959A AR P010102959 A ARP010102959 A AR P010102959A AR 028743 A1 AR028743 A1 AR 028743A1
Authority
AR
Argentina
Prior art keywords
derivatives
triazolilmetil
piperazina
antagonist action
neuroquinine
Prior art date
Application number
ARP010102959A
Other languages
English (en)
Spanish (es)
Inventor
Daniel Jasserand
Uwe Schoen
Reinhard Brueckner
Christian Eeckhout
Holger Sann
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of AR028743A1 publication Critical patent/AR028743A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
ARP010102959A 2000-07-28 2001-06-21 DERIVADOS DE N-TRIAZOLILMETIL-PIPERAZINA CON ACCIoN ANTAGONISTA DE RECEPTORES DE NEUROQUININA AR028743A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10036818A DE10036818A1 (de) 2000-07-28 2000-07-28 Neue N-Triazolylmethyl-Piperazinderivate als Neurokininrezeptor-Antagonisten

Publications (1)

Publication Number Publication Date
AR028743A1 true AR028743A1 (es) 2003-05-21

Family

ID=7650544

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010102959A AR028743A1 (es) 2000-07-28 2001-06-21 DERIVADOS DE N-TRIAZOLILMETIL-PIPERAZINA CON ACCIoN ANTAGONISTA DE RECEPTORES DE NEUROQUININA

Country Status (27)

Country Link
US (1) US6407106B1 (enExample)
EP (1) EP1176144B1 (enExample)
JP (1) JP2002053577A (enExample)
KR (1) KR100924405B1 (enExample)
CN (1) CN1167698C (enExample)
AR (1) AR028743A1 (enExample)
AT (1) ATE244716T1 (enExample)
AU (1) AU779318B2 (enExample)
BR (1) BR0103048A (enExample)
CA (1) CA2354213C (enExample)
CZ (1) CZ301695B6 (enExample)
DE (2) DE10036818A1 (enExample)
DK (1) DK1176144T3 (enExample)
DZ (1) DZ3119A1 (enExample)
ES (1) ES2201007T3 (enExample)
HU (1) HU226687B1 (enExample)
IL (1) IL144299A (enExample)
IN (1) IN191021B (enExample)
NO (1) NO323233B1 (enExample)
NZ (1) NZ513041A (enExample)
PL (1) PL210436B1 (enExample)
PT (1) PT1176144E (enExample)
RU (1) RU2288918C2 (enExample)
SK (1) SK284802B6 (enExample)
TW (1) TWI304403B (enExample)
UA (1) UA73728C2 (enExample)
ZA (1) ZA200105737B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA77515C2 (en) * 2002-04-04 2006-12-15 Diazabicyclo alkane derivatives possessing neuroldnin-nk1 receptor antagonistic activity
IL164787A0 (en) * 2002-04-26 2005-12-18 Lilly Co Eli Tachykinin receptor antagonists
DE60318697T2 (de) * 2002-04-26 2009-01-08 Eli Lilly And Co., Indianapolis Triazolderivate als tachykininrezeptor-antagonisten
EP1638944A1 (en) * 2003-06-12 2006-03-29 Eli Lilly And Company Tachykinin receptor antagonists
US20070082905A1 (en) * 2005-05-27 2007-04-12 De Vries Michiel H Pharmaceutical compositions comprising n-triazolymethyl-piperazine compounds and methods of using same
EP1910316B1 (en) * 2005-07-25 2010-11-10 F. Hoffmann-La Roche AG Substituted triazole derivatives and their use as neurokinin 3 receptor antagonists
PE20081229A1 (es) * 2006-12-01 2008-08-28 Merck & Co Inc Antagonistas de receptor de orexina de diazepam sustituido
KR20090112722A (ko) 2007-01-24 2009-10-28 글락소 그룹 리미티드 3,5-디아미노-6-(2,3-디클로로페닐)-1,2,4-트리아진 또는 ｒ(-)-2,4-디아미노-5-(2,3-디클로로페닐)-6-플루오로메틸 피리미딘 및 ｎｋ1을 포함하는 제약 조성물
US20120258093A1 (en) 2009-08-20 2012-10-11 Institut National De La Sante Et De La Recherche Medicale (Inserm) Vla-4 as a biomarker for prognosis and target for therapy in duchenne muscular dystrophy
NO2729147T3 (enExample) 2011-07-04 2018-02-03
WO2019162519A1 (en) 2018-02-26 2019-08-29 Ospedale San Raffaele S.R.L. Nk-1 antagonists for use in the treatment of ocular pain
WO2021180885A1 (en) 2020-03-11 2021-09-16 Ospedale San Raffaele S.R.L. Treatment of stem cell deficiency
CN115184498B (zh) * 2022-07-15 2023-02-21 山东京卫制药有限公司 N-Boc-哌嗪中有关物质哌嗪的检测方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5883098A (en) 1993-11-29 1999-03-16 Fujisawa Pharmaceutical Co., Ltd. Piperazine derivatives
IL111730A (en) 1993-11-29 1998-12-06 Fujisawa Pharmaceutical Co Piperazine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
US5637592A (en) * 1994-07-12 1997-06-10 Janssen Pharmaceutica N.V. Acyl derivatives of azolones
CN1072220C (zh) * 1995-05-25 2001-10-03 藤泽药品工业株式会社 作为神经激肽受体拮抗剂的1－苯甲酰基－2－(吲哚基－3－烷基)－哌嗪衍生物
GB9513118D0 (en) * 1995-06-28 1995-08-30 Merck Sharp & Dohme Therapeutic agents
JP2000502100A (ja) * 1995-12-18 2000-02-22 藤沢薬品工業株式会社 タキキニン拮抗薬としてのピペラジン誘導体
KR100458346B1 (ko) * 1996-03-29 2005-06-21 듀파 인터내셔날 리서치 베 파우 피페라진및피페리딘화합물
AUPO735997A0 (en) * 1997-06-17 1997-07-10 Fujisawa Pharmaceutical Co., Ltd. Piperazine derivatives
DE19824865A1 (de) * 1997-08-27 1999-03-04 Solvay Pharm Gmbh Neue Harnstoffderivate
EP0899270B1 (de) * 1997-08-27 2008-05-21 Solvay Pharmaceuticals GmbH Indolmethyl-N,N'-bisacylpiperazine als Neurokininrezeptorantagonisten
ES2162731B1 (es) * 1999-06-04 2003-02-16 Faes Fabrica Espanola De Produ Nuevas arilpiperacilnilalquil-3(2h)-piridacinonas.

Also Published As

Publication number Publication date
IL144299A (en) 2004-08-31
CA2354213C (en) 2010-04-27
NO20013709D0 (no) 2001-07-27
HK1042699A1 (en) 2002-08-23
JP2002053577A (ja) 2002-02-19
IL144299A0 (en) 2002-05-23
PT1176144E (pt) 2003-11-28
ATE244716T1 (de) 2003-07-15
NO20013709L (no) 2002-01-29
PL348946A1 (en) 2002-02-11
BR0103048A (pt) 2002-04-02
RU2288918C2 (ru) 2006-12-10
CZ20011813A3 (cs) 2002-03-13
DZ3119A1 (fr) 2004-09-19
AU779318B2 (en) 2005-01-13
EP1176144A1 (de) 2002-01-30
HU0102931D0 (en) 2001-09-28
HU226687B1 (en) 2009-06-29
HUP0102931A3 (en) 2003-07-28
DE50100358D1 (de) 2003-08-14
HUP0102931A2 (hu) 2002-11-28
US6407106B1 (en) 2002-06-18
CN1167698C (zh) 2004-09-22
DK1176144T3 (da) 2003-10-27
SK7572001A3 (en) 2002-02-05
KR20020010482A (ko) 2002-02-04
NZ513041A (en) 2002-12-20
CN1335316A (zh) 2002-02-13
EP1176144B1 (de) 2003-07-09
CA2354213A1 (en) 2002-01-28
ES2201007T3 (es) 2004-03-16
CZ301695B6 (cs) 2010-05-26
AU5767501A (en) 2002-01-31
TWI304403B (en) 2008-12-21
PL210436B1 (pl) 2012-01-31
SK284802B6 (sk) 2005-11-03
US20020065276A1 (en) 2002-05-30
DE10036818A1 (de) 2002-02-07
NO323233B1 (no) 2007-02-05
UA73728C2 (en) 2005-09-15
ZA200105737B (en) 2002-01-22
KR100924405B1 (ko) 2009-10-29
IN191021B (enExample) 2003-09-13

Similar Documents

Publication Publication Date Title
UY28946A1 (es) Compuestos de aril-y heteroaril-alquilanina que contienen pirazol, composiciones farmacéuticas que contienen los compuestos y nuevos productos químicos intermedios
UY27571A1 (es) 2-tio-3, 5-diciano-4-fenil-6-aminopiridinas sustituidas y su uso
UY28572A1 (es) Compuestos novedosos
UY27381A1 (es) 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas y su uso
AR077414A2 (es) Compuestos de piperazina como antagonistas de taquinina sus sales y solvatos composiciones farmaceuticas que lo contienen su uso y procesos para su preparacion
MX9605128A (es) Nuevos derivados de aminoacidos, procedimientos para su preparacion y composiciones farmaceuticas que contienen estos compuestos.
EA200300595A1 (ru) Соединения пиперазинилпиразинов в качестве антагонистов серотонин 5-ht2 рецептора
ES2100907T3 (es) Bencimidazoles, medicamentos que contienen estos compuestos y proced imiento para su preparacion.
HN1999000149A (es) Derivados de 4,4-biarilpiperidina
ES2195785B1 (es) Nuevos derivados de piridazin-3(2h)-ona.
CR8530A (es) Intermediarios de quinolona como inhibidores de receptores de tirosina quinasas y la sintesis de los mismos
PA8575401A1 (es) Derivados de heteroarilamida benzocondensada de tienopiridinas utiles como agentes terapeuticos, composiciones farmaceuticas que incluyen a los mismos y metrodos para su uso
UY26495A1 (es) " derivados de tiazolilamida"
ECSP099394A (es) Derivados de quinuclidinol como antogonistas de receptores muscarínicos
UY27851A1 (es) Difenilazetidinonas sustituidas en anillo, procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso.
AR028743A1 (es) DERIVADOS DE N-TRIAZOLILMETIL-PIPERAZINA CON ACCIoN ANTAGONISTA DE RECEPTORES DE NEUROQUININA
AR021843A1 (es) Derivados de propanolamina sustituidos con heterociclos, procedimiento para su preparacion, y su utilizacion.
ECSP034531A (es) Derivados sustituidos de c-ciclohexilmetilamina
AR035570A1 (es) Derivados de isotiazol
UY27980A1 (es) Indoles 2,7-sustituidos
MXPA04006113A (es) Derivados de triazoloquinolina utiles como ligandos receptores de adenosina.
UY27770A1 (es) Imidazolinilmetil aralquilsulfonamidas
AR028947A1 (es) Compuestos novedosos
ECSP034532A (es) Derivados del 1-aminobutan-3-ol sustituido
TR200402546T4 (tr) Taksan türevleri hazırlamak için işlem.

Legal Events

Date Code Title Description
FG Grant, registration